The majority of prostate cancer patient samples analyzed show GFRA1 protein expression, indicating that increased cell proliferation upon GDNF secretion in the TME and therefore expedited tumor repopulation and clonal outgrowth could contribute to treatment failure in a considerable proportion of prostate cancer cases. This evidence concerns the gene GDNF and prostate cancer.